Triple-negative breast cancer: Could a cancer-killing virus clear up tumors?
Triple-negative breast cancer, which accounts for 15%Trusted Source of newly diagnosed breast cancer cases, is characterized by tumors that lack estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2) receptors.
This means that the tumor cells do not respond to hormone therapy or drugs that target HER2.
